Clinical Benefits

Transforming peripheral neuropathy care with quantitative, objective assessment

Patient management can be positively impacted with DPNCheck by providing healthcare providers with objective, quantitative data for detecting, confirming, and monitoring peripheral neuropathies. Our point-of-care testing brings the gold standard of nerve conduction studies directly to you, enabling immediate clinical decision-making and improved patient outcomes.

Key Clinical Benefits

Early Detection

Detect peripheral neuropathy in its earliest stages, even before symptoms appear. DPNCheck's sensitive nerve conduction measurements can identify pre-clinical neuropathy, allowing for timely intervention and better patient outcomes. Learn about the testing process.

Quantitative Assessment

Move beyond subjective screening tools to obtain objective, quantitative measurements of nerve function. DPNCheck provides precise amplitude and conduction velocity values that help confirm or rule out peripheral neuropathy with clinical certainty. Understanding your test results.

Severity Staging

Accurately stage the severity of peripheral neuropathy with standardized measurements. Clear normal limits (>4 microvolts amplitude & >40 m/s conduction velocity) provide immediate clinical interpretation and severity assessment. Learn more about result interpretation.

Treatment Monitoring

Monitor changes in peripheral neuropathy over time and assess response to treatment interventions. Serial testing provides objective data to track disease progression or improvement with therapeutic interventions.

Risk Stratification

Identify patients at highest risk for neuropathy-related complications including foot ulcers, neuropathic pain, and falls. Early identification enables proactive preventive care and targeted interventions. Learn about risk assessment applications.

Cost-Effective Care

Early diagnosis presents opportunities to intervene before complications develop, reducing long-term healthcare costs. Point-of-care testing eliminates referral delays and provides immediate results for clinical decision-making.

Clinical Practice Advantages

Immediate Results

  • 30-60 second test duration
  • No waiting for referral appointments
  • Same-visit diagnosis and treatment planning
  • Improved patient satisfaction

Easy Implementation

  • Performed by medical assistants or nursing staff
  • Minimal training required
  • No special facility requirements
  • Embedded quality control ensures reliable results

Comprehensive Assessment

  • Standard nerve conduction parameters
  • Sensitive and specific biomarkers
  • Validated in multiple clinical studies
  • Proven accuracy against gold standard testing

Clinical Decision Support

  • Clear normal limits for immediate interpretation
  • Standardized reporting with clinical guidance
  • Integration with electronic medical records
  • Longitudinal tracking capabilities

Validation Statistics

88%

Sensitivity for detecting peripheral neuropathy*

82%

Specificity for ruling out peripheral neuropathy*

44

Peer-reviewed publications

892

Total patients studied across validation trials*

*Summary sensitivity and specificity determined by bivariate meta-analysis across multiple validation studies.
Note: Specificity when referenced against healthy controls is 95%.

Learn More About DPNCheck

Discover how DPNCheck can improve your peripheral neuropathy assessment and patient care. View our clinical evidence, training resources, and implementation guides.

Clinical FAQ View Publications